Transcriptional control of multidrug resistance in the yeast Saccharomyces

W Scott Moye-Rowley1

  • 1Department of Physiology and Biophysics, University of Iowa, Iowa City, Iowa 52242, USA.

Insights

Multidrug resistance in Saccharomyces cerevisiae is a significant challenge. This review explores the genetic networks that control pleiotropic drug resistance (PDR) genes, offering a framework for understanding cellular defense mechanisms.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Multidrug resistance (MDR) in target cells, including those in cancer and fungal infections, poses a major challenge in chemotherapeutic treatments.
  • Certain genetic alterations in Saccharomyces cerevisiae can lead to a pleiotropic drug-resistant (PDR) phenotype, conferring tolerance to a wide spectrum of toxic compounds.
  • The PDR phenotype in yeast is often associated with the overexpression of transporter proteins, driven by mutations in transcriptional regulators or their regulatory inputs.

Purpose of the Study:

  • To provide a comprehensive framework for understanding the regulatory networks that modulate the expression of PDR genes in Saccharomyces cerevisiae.
  • To elucidate the molecular mechanisms underlying the development of pleiotropic drug resistance in yeast.
  • To offer insights into potential strategies for overcoming drug resistance in therapeutic applications.

Main Methods:

  • This review synthesizes findings from various studies investigating PDR gene expression in Saccharomyces cerevisiae.
  • Analysis of genetic mutations affecting transcriptional regulators and their regulatory inputs.
  • Examination of the role of transporter proteins in conferring multidrug resistance.

Main Results:

  • Mutations in transcriptional regulators or their regulatory inputs lead to the overexpression of downstream transporter proteins.
  • This overexpression results in a pleiotropic drug-resistant (PDR) phenotype in Saccharomyces cerevisiae.
  • Understanding these networks is crucial for comprehending cellular resistance mechanisms.

Conclusions:

  • The PDR network in Saccharomyces cerevisiae provides a model system for studying multidrug resistance.
  • Identifying and understanding these regulatory networks can inform strategies to combat drug resistance in various pathological conditions.
  • Further research into these networks may lead to novel therapeutic approaches.

Related Concept Videos

Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Yeast Signaling01:41

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...